Crossject to receive up to €1 million on marketing approvals, plus a markup on sales linked to gross margin Agreement, with undisclosed strategic partner,.
Press Release Crossject reports financial results and business highlights for first half of 2023 Strong progress in bringing drugs for use in emergency situations towards the market .
Crossject announces significant improvement in Gaïa ESG rating finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
05.09.2023 - Press Release Crossject reports successful completion of European and U.S. audits for manufacturing of ZENEO Midazolam for epileptic seizures ISO 13485 certification renewed for manufacturing sites at Gray and Dijon French Health Agency .